encouraged to use the Version of Record that, when published, will replace this version. The most /BCJ

Σχετικά έγγραφα
encouraged to use the Version of Record that, when published, will replace this version. The most /BCJ BIOCHEMICAL JOURNAL

encouraged to use the Version of Record that, when published, will replace this version. The most /BCJ

ΠΡΟΣΚΛΗΣΗ ΕΚΔΗΛΩΣΗΣ ΕΝΔΙΑΦΕΡΟΝΤΟΣ

Longitudinal Changes in Component Processes of Working Memory

encouraged to use the Version of Record that, when published, will replace this version. The most /BCJ

Enzymatic Synthesis of Dithiolopyrrolone Antibiotics Using Cell-Free Extract of Saccharothrix

Supplementary Figure 1

MathCity.org Merging man and maths

Ψηφιακή ανάπτυξη. Course Unit #1 : Κατανοώντας τις βασικές σύγχρονες ψηφιακές αρχές Thematic Unit #1 : Τεχνολογίες Web και CMS

Προσωπική Aνάπτυξη. Ενότητα 2: Διαπραγμάτευση. Juan Carlos Martínez Director of Projects Development Department

Πώς μπορεί κανείς να έχει έναν διερμηνέα κατά την επίσκεψή του στον Οικογενειακό του Γιατρό στο Ίσλινγκτον Getting an interpreter when you visit your

GREECE BULGARIA 6 th JOINT MONITORING

Chapter 1. Fingolimod attenuates ceramide induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

Προσωπική Aνάπτυξη. Ενότητα 4: Συνεργασία. Juan Carlos Martínez Director of Projects Development Department

The Nottingham eprints service makes this work by researchers of the University of Nottingham available open access under the following conditions.

Ψηφιακή ανάπτυξη. Course Unit #1 : Κατανοώντας τις βασικές σύγχρονες ψηφιακές αρχές Thematic Unit #1 : Τεχνολογίες Web και CMS

ΑΛΕΞΑΝΔΡΟΣ ΠΑΛΛΗΣ SCHOOLTIME E-BOOKS

Homework 3 Solutions

Development and Verification of Multi-Level Sub- Meshing Techniques of PEEC to Model High- Speed Power and Ground Plane-Pairs of PFBS

Paper Reference. Paper Reference(s) 1776/04 Edexcel GCSE Modern Greek Paper 4 Writing. Thursday 21 May 2009 Afternoon Time: 1 hour 15 minutes

CYTA Cloud Server Set Up Instructions

Calculating the propagation delay of coaxial cable

A strategy for the identification of combinatorial bioactive compounds. contributing to the holistic effect of herbal medicines

Supplementary Materials: A Preliminary Link between Hydroxylated Metabolites of Polychlorinated Biphenyls and Free Thyroxin in Humans

Cellular Physiology and Biochemistry

Scrum framework: Ρόλοι

Βιοπληροφορική. Ενότητα 2: Βάσεις Δεδομένων (1/3), 1 ΔΩ. Τμήμα: Βιοτεχνολογίας Όνομα καθηγητή: Τ. Θηραίου

Congruence Classes of Invertible Matrices of Order 3 over F 2

New hybrid functional materials based on carbon: synthesis, characterization and study of properties Zygouri, Panagiota

Advanced Subsidiary Unit 1: Understanding and Written Response

SAINT CATHERINE S GREEK SCHOOL ΕΛΛΗΝΙΚΟ ΣΧΟΛΕΙΟ ΑΓΙΑΣ ΑΙΚΑΤΕΡΙΝΗΣ

PHOS π 0 analysis, for production, R AA, and Flow analysis, LHC11h

Προσωπική Aνάπτυξη. Ενότητα 1: Ηγεσία και ενδυνάμωση. Juan Carlos Martínez Director of Projects Development Department

ΠΑΝΔΠΗΣΖΜΗΟ ΠΑΣΡΩΝ ΣΜΖΜΑ ΖΛΔΚΣΡΟΛΟΓΩΝ ΜΖΥΑΝΗΚΩΝ ΚΑΗ ΣΔΥΝΟΛΟΓΗΑ ΤΠΟΛΟΓΗΣΩΝ ΣΟΜΔΑ ΤΣΖΜΑΣΩΝ ΖΛΔΚΣΡΗΚΖ ΔΝΔΡΓΔΗΑ

derivation of the Laplacian from rectangular to spherical coordinates

This is an electronic reprint of the original article. This reprint may differ from the original in pagination and typographic detail.

MSM Men who have Sex with Men HIV -

Smaller. 6.3 to 100 After 1 minute's application of rated voltage at 20 C, leakage current is. not more than 0.03CV or 4 (µa), whichever is greater.

Mathematical model for HIV spreads control program with ART treatment

the total number of electrons passing through the lamp.

VBA Microsoft Excel. J. Comput. Chem. Jpn., Vol. 5, No. 1, pp (2006)

"#$%&#%$'(!)*!+$',+-.$+/!,%&/')0$)#'.,(!1.#2!#$.02)(02+#'!3(456!$'-'+/!+!

Assalamu `alaikum wr. wb.

ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ CYPRUS COMPUTER SOCIETY ΠΑΓΚΥΠΡΙΟΣ ΜΑΘΗΤΙΚΟΣ ΔΙΑΓΩΝΙΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ 6/5/2006

Εργαστήριο Ανάπτυξης Εφαρμογών Βάσεων Δεδομένων. Εξάμηνο 7 ο

Προσωπική Ανάπτυξη. Ενότητα 3: Δικτύωση. Juan Carlos Martínez Director of Projects Development Department

ΠΡΟΣΚΛΗΣΗ ΕΚΔΗΛΩΣΗΣ ΕΝΔΙΑΦΕΡΟΝΤΟΣ

ΕΠΙΧΕΙΡΗΣΙΑΚΗ ΑΛΛΗΛΟΓΡΑΦΙΑ ΚΑΙ ΕΠΙΚΟΙΝΩΝΙΑ ΣΤΗΝ ΑΓΓΛΙΚΗ ΓΛΩΣΣΑ

ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ CYPRUS COMPUTER SOCIETY ΠΑΓΚΥΠΡΙΟΣ ΜΑΘΗΤΙΚΟΣ ΔΙΑΓΩΝΙΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ 24/3/2007

Pax8 and Pax2 are specifically required at different steps of Xenopus pronephros development

w o = R 1 p. (1) R = p =. = 1

ΤΕΧΝΟΛΟΓΙΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΚΥΠΡΟΥ ΣΧΟΛΗ ΓΕΩΠΟΝΙΚΩΝ ΕΠΙΣΤΗΜΩΝ ΒΙΟΤΕΧΝΟΛΟΓΙΑΣ ΚΑΙ ΕΠΙΣΤΗΜΗΣ ΤΡΟΦΙΜΩΝ. Πτυχιακή εργασία

CORDIC Background (4A)

ΟΡΟΛΟΓΙΑ -ΞΕΝΗ ΓΛΩΣΣΑ

Selective mono reduction of bisphosphine

Econ 2110: Fall 2008 Suggested Solutions to Problem Set 8 questions or comments to Dan Fetter 1

Scrum framework: Γεγονότα

4 ος Σταθμός του Cyprus Bowling Tour 2013 ΕΓΚΡΙΣΗ TOURNAMENT INFORMATION Ε.Σ.ΜΠΟ.ΛΕΥΚΩΣΙΑΣ & ΚΕΡΥΝΕΙΑΣ TOURNAMENT DELIMITATIONS

BandPass (4A) Young Won Lim 1/11/14

«ΨΥΧΙΚΗ ΥΓΕΙΑ ΚΑΙ ΣΕΞΟΥΑΛΙΚΗ» ΠΑΝΕΥΡΩΠΑΪΚΗ ΕΡΕΥΝΑ ΤΗΣ GAMIAN- EUROPE

ΠΑΡΑΡΤΗΜΑ ΔΙΕΘΝΕΣ ΠΙΣΤΟΠΟΙΗΤΙΚΟ ΔΙΑΧΕΙΡΙΣΗΣ ΕΡΜΑΤΟΣ INTERNATIONAL BALLAST WATER MANAGEMENT CERTIFICATE

ΕΛΛΗΝΙΚΗ ΔΗΜΟΚΡΑΤΙΑ Ανώτατο Εκπαιδευτικό Ίδρυμα Πειραιά Τεχνολογικού Τομέα. Ξένη Ορολογία. Ενότητα 6: Working Capital

Τ.Ε.Ι. ΔΥΤΙΚΗΣ ΜΑΚΕΔΟΝΙΑΣ ΠΑΡΑΡΤΗΜΑ ΚΑΣΤΟΡΙΑΣ ΤΜΗΜΑ ΔΗΜΟΣΙΩΝ ΣΧΕΣΕΩΝ & ΕΠΙΚΟΙΝΩΝΙΑΣ

Digital Signal Octave Codes (0B)

Πρόσκληση υποβολής προσφοράς

ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ CYPRUS COMPUTER SOCIETY ΠΑΓΚΥΠΡΙΟΣ ΜΑΘΗΤΙΚΟΣ ΔΙΑΓΩΝΙΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ 19/5/2007

ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ

Final Test Grammar. Term C'

(1) Describe the process by which mercury atoms become excited in a fluorescent tube (3)

Εγκατάσταση λογισμικού και αναβάθμιση συσκευής Device software installation and software upgrade

Robust Network Interdiction with Invisible Interdiction Assets

Παραμύθια τησ Χαλιμϊσ, τομ. A Σελύδα 1

CORDIC Background (2A)

Potential Dividers. 46 minutes. 46 marks. Page 1 of 11

Ηλεκτρονικοί Υπολογιστές IV

Appendix to On the stability of a compressible axisymmetric rotating flow in a pipe. By Z. Rusak & J. H. Lee

Math 6 SL Probability Distributions Practice Test Mark Scheme

BD Cytometric Bead Array Flex Set System

Quick Installation Guide

ΠΕΡΙΕΧΟΜΕΝΑ. Κεφάλαιο 1: Κεφάλαιο 2: Κεφάλαιο 3:

FINAL TEST B TERM-JUNIOR B STARTING STEPS IN GRAMMAR UNITS 8-17

TRIAXIAL TEST, CORPS OF ENGINEERS FORMAT

Matrices and Determinants

ACI sécurité informatique KAA (Key Authentification Ambient)

ΕΛΛΗΝΙΚΗ ΔΗΜΟΚΡΑΤΙΑ ΠΑΝΕΠΙΣΤΗΜΙΟ ΚΡΗΤΗΣ. Ψηφιακή Οικονομία. Διάλεξη 7η: Consumer Behavior Mαρίνα Μπιτσάκη Τμήμα Επιστήμης Υπολογιστών

PROMETRA PROGRAMMER PRINT TOOL (REF 91840) For use with Prometra Programmer

CycloVET. Κανόνες επιτραπέζιου παιχνιδιού «Η Επιστροφή του Ποδηλάτη» EXELIA

FOR THE MOMENT, DUE TO ECONOMICAL CRISIS, PRODUCTION OF GICLEE COPIES UNDER REQUEST, IS SUSPENDED.

Instruction Execution Times

Project: 296 File: Title: CMC-E-600 ICD Doc No: Rev 2. Revision Date: 15 September 2010

ΕΚΘΕΣΗ ΑΝΑΛΥΣΗΣ ΕΛΑΙΟΛΑ ΟΥ REPORT OF OLIVE OIL ANALYSIS

Παλεπηζηήκην Πεηξαηώο Τκήκα Πιεξνθνξηθήο Πξόγξακκα Μεηαπηπρηαθώλ Σπνπδώλ «Πξνεγκέλα Σπζηήκαηα Πιεξνθνξηθήο»

Th, Ra, Rn, Po, Pb, Bi, & Tl K x-rays. Rn Kα1. Rn Kα2. 93( 227 Th)/Rn Kβ3. Ra Kα2. Po Kα2 /Bi K α1 79( 227 Th)/Po Kα1. Ra Kα1 /Bi K β1.

MRL HYDRAULIC LIFTS TYPE:

The Project Gutenberg EBook of Gerodimos Pamphletes, by Argyris Eftaliotis

Decision-Making in the Dark: How Pre-Trial Errors Change the Narrative in Criminal Jury Trials

ΕΦΗΜΕΡΙ Α ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ

Reforming the Regulation of Political Advocacy by Charities: From Charity Under Siege to Charity Under Rescue?

상대론적고에너지중이온충돌에서 제트입자와관련된제동복사 박가영 인하대학교 윤진희교수님, 권민정교수님

Transcript:

Biochemical Journal: this is an Accepted Manuscript, not the final Version of Record. You are encouraged to use the Version of Record that, when published, will replace this version. The most up-to-date version is available at http://dx.doi.org/10.1042/bcj20170802. Please cite using the DOI 10.1042/BCJ20170802 ACCEPTED MANUSCRIPT which Use of the open article access is published. articles is Archiving permitted of based non-open on the access terms Archiving Policy of Portland Press ( articles of the specific is permitted Creative in accordance Commons Licence with the under http://www.portlandpresspublishing.com/content/open-access-policy#archiving).

μμ μμ β μ

μ

μ μ

μ μ

μ

μ

μμ μ μ

μ μ μ μ μμ μ μ μ μ μ μ μ μ μ

μ μμ μμ μ μ μ μ μ μ

μ μ μ μ

Rab3A WDTAGQERYRTITTAYYRGAM Rab3B WDTAGQERYRTITTAYYRGAM Rab3C WDTAGQERYRTITTAYYRGAM Rab3D WDTAGQERYRTITTAYYRGAM Rab5A WDTAGQERYHSLAPMYYRGAQ Rab5B WDTAGQERYHSLAPMYYRGAQ Rab5C WDTAGQERYHSLAPMYYRGAQ Rab8A WDTAGQERFRTITTAYYRGAM Rab8B WDTAGQERFRTITTAYYRGAM Rab10 WDTAGQERFHTITTSYYRGAM Rab12 WDTAGQERFNSITSAYYRSAK Rab29 WDIAGQERFTSMTRLYYRDAS Rab35 WDTAGQERFRTITSTYYRGTH Rab43 WDTAGQERFRTITQSYYRSAN Figure 1

A SHEEP POLYCLONAL B RABBIT POLYCLONAL Rab29 Rab3A Rab3B Rab3C Rab3D Rab5A Rab5BRab5C(Rab7L1) Rab8ARab8B Rab10 Rab12 Rab35 Rab43 MLi-2 + - + - + - + - + - + - + - + - + - + - + - + - + - + - Rab3 Rab5 Rab29 (Rab7L1) Rab8 Rab10 Rab12 Rab35 Rab43 MLi-2 + - + - + - + - + - + - + - + - Abcam rabbit number Rab5 pser84 S942D Rab8 pthr72 S874D E8263 E8268 Rab8 pthr72 Rab10 pthr73 S873D E8256 Rab12 pser106 S876D Rab29 pthr71 S877D E8259 E8261 Rab10 pthr73 HA HA Rab29 Rab3A Rab3B Rab3C Rab3D Rab5A Rab5B Rab5CRab8A Rab8B Rab10 Rab12 (Rab7L1) Rab35 Rab43 MLi-2 + - + - + - + - + - + - + - + - + - + - + - + - + - + - Rab3 pthr86 SA082 Rab29 pser72 SA136 Rab35 pthr72 SA083 Rab43 pthr82 SA334 HA Figure 2

A RABBIT POLYCLONAL MEFs G2019S WT WT R1441C WT R1441G WT KO MLi2 - - + - - + - - + - - + - - + - - + - - - E8263 (rabbit polyclonal prab8) Rab8A total 250 kda 250 kda 50 kda E8261 (rabbit polyclonal prab10) MJFF-total Rab10 clone-1 LRRK2 total LRRK2 ps935 -tubulin B 5 E8263 (prab8) E8261 (prab10) Relative prab signal 4 3 2 1 0 G2019S G2019S + MLi-2 WT WT + MLi-2 WT WT + MLi-2 R1441C R1441C + MLi-2 WT WT + MLi-2 R1441G R1441G + MLi-2 WT LRRK2 KO C SHEEP POLYCLONAL IP: total Rab12 WT R1441G MLi-2 - + - + prab12 NS IB: Rab12 ps106 IB: Rab12 ps106 (High exposure) Rab12 IB: total Rab12 Figure 3

A Specificity panel HEK293 overexpressed LRRK2-phosphorylated Rab proteins MJFF number Abcam number Rab3A Rab8A Rab10 Rab35 Rab43 B A549 cell line WT Rab8A Rab10 KO KO MLi-2 - + - + - + C Recombinant in vitro phosphorylated Rab10 Phospho-Rab10 1000 300 100 30 10 3 pg D clone-1 Mouse embryonic fibroblasts LRRK2[R1441G] clone-2 clone-3 clone-4 clone-5 clone-6 clone-7 clone-8 108-10 83-4 136-1 108-1 22-5 233-3 250-7 279-2 279-6 MLi-2 - + - + - + - + - + - + - + - + - + clone-9 MJFF-pRAB10 clone-1 MJF-21-108-10 250 kda 150 kda 100 kda MJFF-pRAB10 clone-2 MJF-21-83-4 75 kda 50 kda MJFF-pRAB10 clone-3 MJF-21-136-1 37 kda MJFF-pRAB10 clone-4 MJF-21-108-1 MJFF-pRAB10 clone-5 MJF-21-22-5 E Mouse embryonic fibroblasts MJFF-pRAB10 clone-6 MJF-21-233-3 G2019S WT WT R1441C WT R1441G WT KO MLi-2 - - + - - + - - + - - + - - + - - + - - - MJFF-pRAB10 clone-7 MJF-21-250-7 MJFF-pRab10 clone-1 (MJF-21-108-10) MJFF-pRAB10 clone-8 MJF-21-279-2 Ei 6 MJFF-total Rab10 clone-1 MJFF-pRAB10 clone-9 MJF-21-279-6 HA Total Rab8A Total Rab10 Total Rab10 Relative prab10 signal 4 2 0 -Tubulin G2019S G2019S + MLi-2 WT WT + MLi-2 WT WT + MLi-2 R1441C R1441C + MLi-2 WT WT + MLi-2 R1441G R1441G + MLi-2 WT LRRK2 KO Figure 4

A clone-1 clone-2 clone-3 clone-4 clone-5 clone-6 clone-7 clone-8 clone-9 MJF-21-108-10 MJF-21-83-4 MJF-21-136-1 MJF-21-108-1 MJF-21-22-5 MJF-21-233-3 MJF-21-250-7 MJF-21-279-2 MJF-21-279-6 WT RG WT RG WT RG WT RG WT RG WT RG WT RG WT RG WT RG MLi-2 - + - + - + - + - + - + - + - + - + - + - + - + - + - + - + - + - + - + 250 kda 150 kda 100 kda * NS 75 kda 50 kda SPLEEN 37 kda B 250 kda 150 kda 100 kda 75 kda 50 kda LUNG 37 kda C 250 kda 150 kda 100 kda 75 kda 50 kda KIDNEY 37 kda * NS D 250 kda 150 kda 100 kda * NS 75 kda 50 kda 37 kda BRAIN * NS E LUNG SPLEEN KIDNEY BRAIN WT RG WT RG WT RG WT RG MLi2 - + - + - + - + - + - + - + - + 250 kda 250 kda 50 kda IB: LRRK2 IB: LRRK2 ps935 IB: -Tubulin IB: Rab10 Figure 5

A MOUSE TISSUES (LRRK2 R1441C, 10 mg/kg MLi-2) LUNG SPLEEN KIDNEY BRAIN MLi-2 - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - + + + MOUSE 1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10 3 4 5 8 9 10 250 kda 150 kda 100 kda 75 kda 50 kda * NS clone-1 MJF-21-108-10 37 kda * NS * NS 250 kda 150 kda 100 kda 75 kda 50 kda clone-2 MJF-21-83-4 37 kda * NS 250 kda 250 kda MJFF-total Rab10 clone-1 LRRK2 total LRRK2 ps935 37 kda GAPDH B 100 MJFF-pRab10 clone-1 MJF-21-108-10 SIGNAL QUANTITATION 100 MJFF-pRab10 clone-2 MJF-21-83-4 SIGNAL QUANTITATION Relative prab10/gapdh signal 10 1 Relative prab10/gapdh signal 10 1 0.1 LUNG LUNG + MLi-2 SPLEEN SPLEEN + MLi-2 KIDNEY KIDNEY + MLi-2 BRAIN BRAIN + MLi-2 0.1 LUNG LUNG + MLi-2 SPLEEN SPLEEN + MLi-2 KIDNEY KIDNEY + MLi-2 BRAIN BRAIN + MLi-2 Figure 6

A Relative prab10 signal 2.5 2.0 1.5 1.0 0.5 0.0 Ctrl IPD * * * * * * Ctrl IPD Ctrl IPD 1 2 3 4 5 6 7 1 2 3 4 5 6 7 8 9 10 11 8 9 11 12 13 14 15 1612 13 14 15 16 1718 20 21 23 17 1819 20 21 22 23 24 24 25 26 27 28 29 30 25 MJFF-pRab10 clone-1 25 Rab10 25 Rab8a 250 37 LRRK2 p-erk1/2 37 ERK1/2 37 GAPDH Immunoblot B Ctrl IPD Ctrl IPD Ctrl IPD Ctrl IPD Ctrl IPD 1 2 3 4 5 1 2 3 4 5 6 6 7 8 9 11 7 8 9 10 1112 12 13 14 15 16 131415 16 17 18 17 18 19 20 20 2123 24 25 21 22 23 24 26 27 28 29 30 + Phospho-Rab 10 Total Rab 10 C 250 150 100 75 50 37 Ctrl IPD Ctrl IPD Ctrl IPD 1 2 1 2 1 2 1 2 1 2 1 2 Phos-tag immunoblot 25 20 83-4 108-10 136-1 MJFF-pRAB10 clone-2 MJFF-pRAB10 clone-1 MJFF-pRAB10 clone-3 25 37 Rab10 GAPDH Figure 7

A Specificity panel HEK293 overexpressed LRRK2-phosphorylated Rab proteins MJFF number Abcam number Rab3A Rab8A Rab10 Rab35 Rab43 B A549 cell line WT MLi-2 - + - + - + C Rab8A Rab10 KO KO Recombinant in vitro phosphorylated Rab8A Phospho-Rab8A 1000 pg 300 100 30 10 3 MJFF-pRAB8 clone-1 MJF-20-25-2 MJFF-pRAB8 clone-2 MJF-20-55-4 MJFF-pRAB8 clone-3 MJF-20-19-6 MJFF-pRAB8 clone-4 MJF-20-19-3 MJFF-pRAB8 clone-5 MJF-20-25-5 MJFF-pRAB8 clone-6 MJF-20-38-1 MJFF-pRAB8 clone-7 MJF-20-55-3 MJFF-pRAB8 clone-8 MJF-20-58-2 MJFF-pRAB8 clone-9 MJF-20-58-6 HA Total Rab8A Total Rab8A Total Rab10 -Tubulin Figure 8

Immunoprecipitation of endogenous Rab proteins MLi2 - + - + - + - + - + - + IP: MJFF-pRab8 clone-1 MJF-20-25-2 IP: MJFF-pRab8 clone-2 MJF-20-55-4 IP: Polyclonal prab8 E8263 WT RC WT RC WT RC IB: Rab8A IB: Rab10 IB: Rab35 Figure 9

A HEK293 HA-Rab8A overexpression 3000 3000 1000 300 100 30 10 MLi-2 + - - - - - - ng B HEK293 HA-Rab10 overexpression 3000 3000 1000 IB: MJFF-pRAB8 clone-1 (MJF-20-25-2) IB: Rab8A (CST) 300 100 30 10 MLi-2 + - - - - - - ng Phospho- Immunoblot * Phospho- Immunoblot * IB: MJFF-pRAB10 clone-1 (MJF-21-108-10) IB: Rab10 (CST) Phos-tag IB: MJFF-pRAB8 clone-1 (MJF-20-25-2) * * IB: Rab8A (CST) Phos-tag IB: MJFF-pRAB10 clone-1 (MJF-21-108-10) IB: Rab10 (CST) Rab8 Rab10 Figure 10

Supplementary Figure 1 ANTIBODY WB (lysates of overexpressing cells) BLEED 1st 2nd 3rd 4th 5th 6th 7th 8th 9th 10th 11th 12th Rab3 pthr86 (SA082) Rab5 pser84 (S942D) Rab7L1 (Rab29) pthr71 (S877D) Rab7L1 (Rab29) pser72 (SA136) Rab8 pthr72 (S874D) Rab10 pthr73 (S873D) Rab12 pser106 (S876D) Rab35 pthr72 (SA083) Rab43 pthr82 (SA334 ) GOOD SIGNAL WEAK SIGNAL NO SIGNAL BLEED NOT AVAILABLE

Table 1. Antigens employed for sheep polyclonal phospho-specific and total Rab antibodies ANTIBODY SHEEP NUMBER ANTIGEN Rab3 pthr86 SA082 CAGQERYRT*ITTAYYR Rab5 pser84 S942D CAGQERYHS*LAPMYYR Rab7L1 (Rab29) pthr71 S877D CIAGQERFT*SMTRLYYR Rab7L1 (Rab29) pser72 SA136 CDIAGQERFTS*MTRLYYRSS Rab8 pthr72 S874D CAGQERFRT*ITTAYYR Rab10 pthr73 S873D CAGQERFHT*ITTSYYR Rab12 pser106 S876D CAGQERFNS*ITSAYYR Rab35 pthr72 SA083 CAGQERFRT*ITSTYYR Rab43 pthr82 SA334 CAGQERFRT*ITQSYYR Rab12 total Rab35 total Rab43 total SA227 SA314 SA135 Phosphorylated serine/threonine marked with S*/T* Rab12 (no epitope tag) (anity puried with 6HIS-SUMO-Rab12) GST-Rab35 (anity puried with MBP-Rab35) GST-Rab43 (anity puried with HIS-SUMO-Rab43)

Table 2. Antigens employed for rabbit polyclonal and monoclonal phospho-specific Rab antibodies ANTIBODY Rab8 pthr72 Rab10 pthr73 ABCAM project number MJF-20 MJF-21 ANTIGEN C-Ahx-AGQERFRT*ITTAYYR-amide Ac-AGQERFRT*ITTAYYR-Ahx-C C-Ahx-AGQERFHT*ITTSYYR-amide Ac-AGQERFHT*ITTSYYR-Ahx-C Phosphorylated serine/threonine marked with S*/T* RABBIT NUMBERS E8262- E8269 E8254- E8261 NAME OF FINAL MONOCLONAL ANTIBODIES MJFF-pRab8 MJFF-pRab10

Table 3. MJFF-pRab8 and MJFF-pRab10 monoclonal phospho-specific Rab antibodies MJFF CLONE NAME MJFF-pRab8 clone-1 MJFF-pRab8 clone-2 MJFF-pRab8 clone-3 MJFF-pRab8 clone-4 MJFF-pRab8 clone-5 MJFF-pRab8 clone-6 MJFF-pRab8 clone-7 MJFF-pRab8 clone-8 MJFF-pRab8 clone-9 MJFF-pRab10 clone-1 MJFF-pRab10 clone-2 MJFF-pRab10 clone-3 MJFF-pRab10 clone-4 MJFF-pRab10 clone-5 MJFF-pRab10 clone-6 MJFF-pRab10 clone-7 MJFF-pRab10 clone-8 MJFF-pRab10 clone-9 ABCAM CATALOG NUMBER MJF-20-25-2 MJF-20-55-4 MJF-20-19-6 MJF-20-19-3 MJF-20-25-5 MJF-20-38-1 MJF-20-55-3 MJF-20-58-2 MJF-20-58-6 MJF-21-108-10 MJF-21-83-4 MJF-21-136-1 MJF-21-108-1 MJF-21-22-5 MJF-21-233-3 MJF-21-250-7 MJF-21-279-2 MJF-21-279-6